Scott Gottlieb, MD

Resident Fellow · American Enterprise Institute

Policy & RegulationNorth AmericaLarge following

Why follow Scott

He delivers timely analysis of drug development pipelines, FDA approval processes, and public health policy. His commentary covers market access trends and pharmaceutical industry updates.

Writes about

FDA ApprovalDrug DevelopmentPublic Health Policy

Best for

Biotech executives, investors, and public health analysts.